Table of Contents
ISRN Pharmacology
Volume 2013 (2013), Article ID 615685, 5 pages
http://dx.doi.org/10.1155/2013/615685
Research Article

Role of Monoaminergic System in the Etiology of Olive Oil Induced Antidepressant and Anxiolytic Effects in Rats

Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi 75270, Pakistan

Received 16 May 2013; Accepted 13 June 2013

Academic Editors: T. Kumai and T. B. Vree

Copyright © 2013 Tahira Perveen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Aguilera, M. C. Ramírez-Tortosa, M. D. Mesa, and Á. Gil, “Protective effects of monounsaturated fatty acids and polyunsaturated fatty acids in the development of cardiovascular disease,” Nutricion Hospitalaria, vol. 16, no. 3, pp. 78–91, 2001. View at Google Scholar · View at Scopus
  2. C. Alarcón de la Lastra, M. D. Barranco, V. Motilva, and J. M. Herrerías, “Mediterranean diet and health: biological importance of olive oil,” Current Pharmaceutical Design, vol. 7, no. 10, pp. 933–950, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Coni, R. Di Benedetto, M. Di Pasquale et al., “Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits,” Lipids, vol. 35, no. 1, pp. 45–54, 2000. View at Google Scholar · View at Scopus
  4. A. Keys, A. Menotti, and M. J. Karvonen, “The diet and 15-year death rate in the seven countries study,” American Journal of Epidemiology, vol. 124, no. 6, pp. 903–915, 1986. View at Google Scholar · View at Scopus
  5. G. I. Togna, A. R. Togna, M. Franconi, C. Marra, and M. Guiso, “Olive oil isochromans inhibit human platelet reactivity,” Journal of Nutrition, vol. 133, no. 8, pp. 2532–2536, 2003. View at Google Scholar · View at Scopus
  6. M.-I. Covas, “Olive oil and the cardiovascular system,” Pharmacological Research, vol. 55, no. 3, pp. 175–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Bondia-Pons, H. Schröder, M.-I. Covas et al., “Moderate consumption of olive oil by healthy european men reduces systolic blood pressure in non-mediterranean participants,” Journal of Nutrition, vol. 137, no. 1, pp. 84–87, 2007. View at Google Scholar · View at Scopus
  8. C. Romero, E. Medina, J. Vargas, M. Brenes, and A. De Castro, “In vitro activity of olive oil polyphenols against helicobacter pylori,” Journal of Agricultural and Food Chemistry, vol. 55, no. 3, pp. 680–686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Machowetz, H. E. Poulsen, S. Gruendel et al., “Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans,” FASEB Journal, vol. 21, no. 1, pp. 45–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Solfrizzi, F. Panza, F. Torres et al., “High monounsaturated fatty acids intake protects against age-related cognitive decline,” Neurology, vol. 52, no. 8, pp. 1563–1569, 1999. View at Google Scholar · View at Scopus
  11. A. C. Logan, “Neurobehavioural aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression,” Alternative Medicine Review, vol. 8, no. 4, pp. 410–425, 2003. View at Google Scholar · View at Scopus
  12. L. A. Ferrara, A. S. Raimondi, L. D'Episcopo, L. Guida, A. D. Russo, and T. Marotta, “Olive oil and reduced need for antihypertensive medications,” Archives of Internal Medicine, vol. 160, no. 6, pp. 837–842, 2000. View at Google Scholar · View at Scopus
  13. J. Bradbury, S. P. Myers, and C. Oliver, “An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study,” Nutrition Journal, vol. 3, article 20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Takeuchi, Y. Kondo, M. Yanagi, and M. Yoshikawa, “Accelerative effect of olive oil on adrenal corticosterone secretion in rats loaded with single or repetitive immersion-restraint stress,” Journal of Nutritional Science and Vitaminology, vol. 46, no. 4, pp. 158–164, 2000. View at Google Scholar · View at Scopus
  15. I. Andreadou, E. K. Iliodromitis, E. Mikros et al., “The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits,” Journal of Nutrition, vol. 136, no. 8, pp. 2213–2219, 2006. View at Google Scholar · View at Scopus
  16. M. González-Santiago, E. Martín-Bautista, J. J. Carrero et al., “One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development,” Atherosclerosis, vol. 188, no. 1, pp. 35–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Paiva-Martins and M. H. Gordon, “Interactions of ferric ions with olive oil phenolic compounds,” Journal of Agricultural and Food Chemistry, vol. 53, no. 7, pp. 2704–2709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Pitozzi, M. Jacomelli, M. Zaid et al., “Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats,” British Journal of Nutrition, vol. 103, no. 11, pp. 1674–1683, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gupta, G. Vij, and K. Chopra, “Possible role of oxidative stress and immunological activation in mouse model of chronic fatigue syndrome and its attenuation by olive extract,” Journal of Neuroimmunology, vol. 226, no. 1-2, pp. 3–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. I. M. Berquin, Y. Min, R. Wu et al., “Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids,” Journal of Clinical Investigation, vol. 117, no. 7, pp. 1866–1875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. A. Thomas, M. J. Carson, and J. G. Sutcliffe, “Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling,” Annals of the New York Academy of Sciences, vol. 861, pp. 183–189, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Haider, S. Saleem, S. Shameem, S. P. Ahmed, T. Parveen, and D. J. Haleem, “Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration,” Polish Journal of Pharmacology, vol. 56, no. 1, pp. 73–78, 2004. View at Google Scholar · View at Scopus
  23. T. Parveen, B. Nazi, N. Amin, and D. J. Haleem, “Repeated administration of vitamin E decreases 5HIAA levels producing antidepressant effect and enhance behavioral effects,” Pakistan Journal of Biochemistry and Molecular Biology, vol. 43, no. 4, pp. 169–173, 2011. View at Google Scholar
  24. M. J. Detke, J. Johnson, and I. Lucki, “Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression,” Experimental and Clinical Psychopharmacology, vol. 5, no. 2, pp. 107–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Hamazaki, S. Sawazaki, T. Nagasawa, Y. Nagao, Y. Kanagawa, and K. Yazawa, “Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress,” Lipids, vol. 34, pp. S33–S37, 1999. View at Publisher · View at Google Scholar
  26. M. Maes, A. Christophe, E. Bosmans, A. Lin, and H. Neels, “In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress,” Biological Psychiatry, vol. 47, no. 10, pp. 910–920, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. C. R. Sirtori, J. W. Anderson, and A. Arnoldi, “Nutritional and nutraceutical considerations for dyslipidemia,” Future Lipidology, vol. 2, no. 3, pp. 313–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. B. W. Dunlop and C. B. Nemeroff, “The role of dopamine in the pathophysiology of depression,” Archives of General Psychiatry, vol. 64, no. 3, pp. 327–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Hasler, “Pathophysiology of depression: do we have any solid evidence of interest to clinicians?” World Psychiatry, vol. 9, no. 3, pp. 155–161, 2010. View at Google Scholar · View at Scopus
  30. L. Sher, M. A. Oquendo, S. Li et al., “Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism,” Neuropsychopharmacology, vol. 28, no. 9, pp. 1712–1719, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. D. S. Robinson, “The role of dopamine and norepinephrine in depression,” Primary Psychiatry, vol. 14, no. 5, pp. 21–23, 2007. View at Google Scholar · View at Scopus